UBS Group’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.9M | Sell |
869,222
-77,484
| -8% | -$3.93M | 0.01% | 1903 |
|
|
2026
Q1 | $50.5M | Sell |
946,706
-75,836
| -7% | -$4.45M | 0.01% | 1626 |
|
|
2025
Q4 | $63.6M | Sell |
1,022,542
-27,318
| -3% | -$1.69M | 0.01% | 1389 |
|
|
2025
Q3 | $63.1M | Sell |
1,049,860
-92,586
| -8% | -$5.66M | 0.01% | 1401 |
|
|
2025
Q2 | $71.6M | Sell |
1,142,446
-76,431
| -6% | -$4.59M | 0.01% | 1216 |
|
|
2025
Q1 | $73.4M | Sell |
1,218,877
-30,835
| -2% | -$1.92M | 0.01% | 1140 |
|
|
2024
Q4 | $72.9M | Buy |
1,249,712
+104,432
| +9% | +$6.21M | 0.01% | 1140 |
|
|
2024
Q3 | $67.8M | Sell |
1,145,280
-400,880
| -26% | -$22.9M | 0.01% | 952 |
|
|
2024
Q2 | $86.6M | Buy |
1,546,160
+280,267
| +22% | +$15.7M | 0.02% | 717 |
|
|
2024
Q1 | $74.2M | Sell |
1,265,893
-58,415
| -4% | -$3.3M | 0.02% | 806 |
|
|
2023
Q4 | $71.5M | Buy |
1,324,308
+80,033
| +6% | +$3.91M | 0.02% | 761 |
|
|
2023
Q3 | $60.3M | Sell |
1,244,275
-122,800
| -9% | -$6.53M | 0.02% | 731 |
|
|
2023
Q2 | $77.2M | Sell |
1,367,075
-8,164
| -0.6% | -$450K | 0.03% | 604 |
|
|
2023
Q1 | $74.2M | Sell |
1,375,239
-115,773
| -8% | -$6.16M | 0.03% | 579 |
|
|
2022
Q4 | $78.4M | Sell |
1,491,012
-3,713
| -0.2% | -$188K | 0.03% | 592 |
|
|
2022
Q3 | $70.5M | Buy |
1,494,725
+3,311
| +0.2% | +$172K | 0.03% | 546 |
|
|
2022
Q2 | $75.2M | Sell |
1,491,414
-321,704
| -18% | -$17.5M | 0.03% | 544 |
|
|
2022
Q1 | $111M | Buy |
1,813,118
+37,743
| +2% | +$2.25M | 0.04% | 488 |
|
|
2021
Q4 | $117M | Buy |
1,775,375
+56,412
| +3% | +$3.61M | 0.03% | 541 |
|
|
2021
Q3 | $108M | Sell |
1,718,963
-175,975
| -9% | -$11.2M | 0.03% | 507 |
|
|
2021
Q2 | $114M | Sell |
1,894,938
-216,078
| -10% | -$12.5M | 0.04% | 474 |
|
|
2021
Q1 | $116M | Sell |
2,111,016
-171,180
| -8% | -$9.49M | 0.04% | 450 |
|
|
2020
Q4 | $124M | Buy |
2,282,196
+81,990
| +4% | +$4.29M | 0.04% | 411 |
|
|
2020
Q3 | $110M | Buy |
2,200,206
+64,824
| +3% | +$3.14M | 0.04% | 373 |
|
|
2020
Q2 | $94.2M | Buy |
2,135,382
+299,988
| +16% | +$12.8M | 0.04% | 386 |
|
|
2020
Q1 | $68.9M | Sell |
1,835,394
-162,438
| -8% | -$6.84M | 0.03% | 448 |
|
|
2019
Q4 | $88M | Buy |
1,997,832
+55,116
| +3% | +$2.32M | 0.03% | 500 |
|
|
2019
Q3 | $80.1M | Buy |
1,942,716
+243,996
| +14% | +$9.99M | 0.03% | 475 |
|
|
2019
Q2 | $68.2M | Buy |
1,698,720
+296,496
| +21% | +$11.2M | 0.03% | 534 |
|
|
2019
Q1 | $54.1M | Buy |
1,402,224
+234,954
| +20% | +$8.53M | 0.02% | 597 |
|
|
2018
Q4 | $38.9M | Sell |
1,167,270
-12,426
| -1% | -$430K | 0.02% | 718 |
|
|
2018
Q3 | $44.7M | Buy |
1,179,696
+172,554
| +17% | +$6.13M | 0.02% | 734 |
|
|
2018
Q2 | $33.7M | Buy |
1,007,142
+86,142
| +9% | +$2.81M | 0.01% | 867 |
|
|
2018
Q1 | $28.4M | Buy |
921,000
+52,968
| +6% | +$1.63M | 0.01% | 934 |
|
|
2017
Q4 | $25.1M | Buy |
868,032
+75,462
| +10% | +$2.18M | 0.01% | 1045 |
|
|
2017
Q3 | $22.1M | Buy |
792,570
+51,432
| +7% | +$1.42M | 0.01% | 1048 |
|
|
2017
Q2 | $20.6M | Buy |
741,138
+120,954
| +20% | +$3.2M | 0.01% | 1026 |
|
|
2017
Q1 | $15.7M | Sell |
620,184
-74,004
| -11% | -$1.79M | 0.01% | 1184 |
|
|
2016
Q4 | $15.4M | Sell |
694,188
-191,856
| -22% | -$4.36M | 0.01% | 1195 |
|
|
2016
Q3 | $21.5M | Buy |
886,044
+166,056
| +23% | +$3.95M | 0.01% | 934 |
|
|
2016
Q2 | $16.3M | Sell |
719,988
-5,166
| -0.7% | -$112K | 0.01% | 1069 |
|
|
2016
Q1 | $14.8M | Sell |
725,154
-346,404
| -32% | -$6.73M | 0.01% | 1075 |
|
|
2015
Q4 | $21.9M | Buy |
1,071,558
+561,264
| +110% | +$11.2M | 0.01% | 902 |
|
|
2015
Q3 | $9.46M | Sell |
510,294
-1,848
| -0.4% | -$37.2K | 0.01% | 1419 |
|
|
2015
Q2 | $10.2M | Buy |
512,142
+10,872
| +2% | +$218K | 0.01% | 1464 |
|
|
2015
Q1 | $10.1M | Sell |
501,270
-28,962
| -5% | -$565K | 0.01% | 1475 |
|
|
2014
Q4 | $10M | Buy |
+530,232
| New | +$9.57M | 0.01% | 1508 |
|
Other funds holding IHI
AAS
UBS Group's IHI Position: Q2 2026 in Review
UBS Group reduced its iShares US Medical Devices ETF (IHI) stake by 8.2% in Q2 2026, selling an estimated $3.93M and leaving 869,222 shares worth $42.9M. The position accounts for 0.01% of the portfolio, ranked #1903.
UBS Group first reported a position in IHI in Q4 2014 and has held it in 47 quarters since. The position peaked at $124M in Q4 2020. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- UBS Group held 869,222 shares of iShares US Medical Devices ETF worth $42.9M as of Q2 2026.
- UBS Group sold 77,484 iShares US Medical Devices ETF shares in Q2 2026, an estimated $3.93M.
- iShares US Medical Devices ETF made up 0.01% of UBS Group's portfolio in Q2 2026, its #1903 holding.
- UBS Group first reported a position in iShares US Medical Devices ETF in Q4 2014 and has held it in 47 quarters since.
- UBS Group's iShares US Medical Devices ETF position peaked at $124M in Q4 2020.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.